The current study systematically analyzed the relationships between p16 expression and prognostic index and clinicopathological parameters in patients with bladder cancer and showed that low expression of p16 was closely correlated with poor prognosis (Figure 5). This evidence concerns the gene CDKN2A and urinary bladder cancer.